Simpler noninstrumented batch and semicontinuous cultures provide mammalian cell kinetic data comparable to continuous and perfusion cultures

Perfusion culture optimization in multiple noninstrumented small‐scale flasks allows reduced expense and time associated with process development. These cultures normally use a different process mode because at small scales it is not practical to retain the cells for medium perfusion. In this work, the kinetics of growth, nutrient consumption, metabolite, and product formation were compared in spinner cultures operated in batch, semicontinuous, chemostat, and perfusion modes. Fed‐batch was also included to provide an added comparison. Using logistic fitting for more reliable specific rate estimates in transient conditions, the growth phase of batch cultures predicted similar kinetics to fed‐batch and continuous processes. For daily medium exchange rates up to 50%, the semicontinuous mode also predicted the perfusion process kinetics. Differences between the chemostat and semicontinuous culture results were only observed at higher exchange rates with the greatest daily culture perturbation. Overall, the batch or semicontinuous cultures were shown to readily provide results similar to the far more complex to operate chemostat or perfusion cultures.

[1]  P. Runstadler,et al.  Cultivation of hybridoma cells in continuous cultures: Kinetics of growth and product formation , 1989, Biotechnology and Bioengineering.

[2]  Carole Heath,et al.  Cell Culture Process Development: Advances in Process Engineering , 2007, Biotechnology progress.

[3]  H. Kataoka,et al.  Kinetic study on HBs-MAb production in continuous cultivation. , 1994, Journal of biotechnology.

[4]  T. Bibila,et al.  In Pursuit of the Optimal Fed‐Batch Process for Monoclonal Antibody Production , 1995, Biotechnology progress.

[5]  Daniel I. C. Wang,et al.  High cell density and high monoclonal antibody production through medium design and rational control in a bioreactor. , 2000, Biotechnology and bioengineering.

[6]  D. Robinson,et al.  Kinetics of recombinant immunoglobulin production by mammalian cells in continuous culture , 1991, Biotechnology and bioengineering.

[7]  R. Mutharasan,et al.  Strategies to extend longevity of hybridomas in culture and promote yield of monoclonal antibodies , 1987, Biotechnology Letters.

[8]  Approximation of continuous fermentation by semicontinuous cultures , 1990, Biotechnology and bioengineering.

[9]  A. Sinskey,et al.  Mathematical descriptions of hybridoma culture kinetics: II. The relationship between thiol chemistry and the degradation of serum activity , 1989, Biotechnology and bioengineering.

[10]  B. Buckland,et al.  Fed-batch culture of recombinant NS0 myeloma cells with high monoclonal antibody production. , 1997, Biotechnology and bioengineering.

[11]  J. Barford,et al.  A study of hybridoma cell growth and antibody production kinetics in continuous culture , 1987 .

[12]  S. Reuveny,et al.  Comparison of cell propagation methods for their effect on monoclonal antibody yield in fermentors , 1986 .

[13]  B. Buckland,et al.  Monoclonal Antibody Process Development Using Medium Concentrates , 1994, Biotechnology progress.

[14]  O. Merten,et al.  Kinetic analysis of hybridoma growth and monoclonal antibody production in semicontinuous culture , 1992, Biotechnology and bioengineering.

[15]  H. Blanch,et al.  Continuous hybridoma suspension cultures with and without cell retention: kinetics of growth, metabolism and product formation. , 1992, Journal of biotechnology.

[16]  D K Robinson,et al.  Effect of specific growth rates on productivity in continuous open and partial cell retention animal cell bioreactors. , 1992, Journal of biotechnology.

[17]  Wei-Shou Hu,et al.  Fedbatch culture and dynamic nutrient feeding. , 2006, Advances in biochemical engineering/biotechnology.

[18]  A. Zeng,et al.  Determinants and rate laws of growth and death of hybridoma cells in continuous culture. , 1998, Biotechnology and bioengineering.

[19]  F Meuwly,et al.  Potential of cell retention techniques for large‐scale high‐density perfusion culture of suspended mammalian cells , 2003, Biotechnology and bioengineering.

[20]  J Tramper,et al.  Metabolic-flux analysis of continuously cultured hybridoma cells using (13)CO(2) mass spectrometry in combination with (13)C-lactate nuclear magnetic resonance spectroscopy and metabolite balancing. , 2001, Biotechnology and bioengineering.

[21]  J. E. Dowd,et al.  Increased t‐PA Yields Using Ultrafiltration of an Inhibitory Product from CHO Fed‐Batch Culture , 2000, Biotechnology progress.

[22]  Liangzhi Xie,et al.  Fed‐batch cultivation of animal cells using different medium design concepts and feeding strategies , 1994, Biotechnology and bioengineering.

[23]  B O Palsson,et al.  Effects of ammonia and lactate on hybridoma growth, metabolism, and antibody production , 1992, Biotechnology and bioengineering.

[24]  R. E. Spier,et al.  Some myths and messages concerning the batch and continuous culture of animal cells , 1997, Cytotechnology.

[25]  H. Blanch,et al.  Cell retention–chemostat studies of hybridoma cells—analysis of hybridoma growth and metabolism in continuous suspension culture in serum‐free medium , 1993, Biotechnology and bioengineering.

[26]  Klaus Joeris,et al.  Logistic Equations Effectively Model Mammalian Cell Batch and Fed‐Batch Kinetics by Logically Constraining the Fit , 2005, Biotechnology progress.

[27]  N. Kalogerakis,et al.  Kinetic data for the BM‐5 insect cell line in repeated‐batch suspension cultures , 1991, Biotechnology and bioengineering.

[28]  A. Zeng Mathematical modeling and analysis of monoclonal antibody production by hybridoma cells , 1996, Biotechnology and bioengineering.

[29]  E. C. Beuvery,et al.  Effect of dilution rate on growth, productivity, cell cycle and size, and shear sensitivity of a hybridoma cell in a continuous culture , 1993, Biotechnology and bioengineering.

[30]  Fractional Factorial Study of Hybridoma Behavior. 2. Kinetics of Nutrient Uptake and Waste Production , 1993, Biotechnology progress.

[31]  Mohamed Al-Rubeai,et al.  Specific monoclonal antibody productivity and the cell cycle-comparisons of batch, continuous and perfusion cultures , 2006, Cytotechnology.

[32]  W M Miller,et al.  A kinetic analysis of hybridoma growth and metabolism in batch and continuous suspension culture: Effect of nutrient concentration, dilution rate, and pH , 2000, Biotechnology and bioengineering.

[33]  R. Mutharasan,et al.  Cell cycle‐ and growth phase‐dependent variations in size distribution, antibody productivity, and oxygen demand in hybridoma cultures , 1990, Biotechnology and bioengineering.

[34]  P. Dhurjati,et al.  Fractional Factorial Study of Hybridoma Behavior. 1. Kinetics of Growth and Antibody Production , 1993, Biotechnology progress.

[35]  A J Sinskey,et al.  Mathematical descriptions of hybridoma culture kinetics: I. Initial metabolic rates , 1988, Biotechnology and bioengineering.

[36]  Paul W. Sauer,et al.  A high-yielding, generic fed-batch cell culture process for production of recombinant antibodies. , 2000, Biotechnology and bioengineering.

[37]  D F Ollis,et al.  Enhanced Antibody Production at Slowed Growth Rates: Experimental Demonstration and a Simple Structured Model , 1990, Biotechnology progress.

[38]  J. Goergen,et al.  Comparison of specific rates of hybridoma growth and metabolism in batch and continuous cultures , 2004, Cytotechnology.

[39]  R. Kurkela,et al.  Pilot-scale production of murine monoclonal antibodies in agitated, ceramic-matrix or hollow-fiber cell culture systems. , 1993, BioTechniques.

[40]  H. Blanch,et al.  A kinetic analysis of hybridoma growth and metabolism in continuous suspension culture on serum‐free medium , 1991, Biotechnology and bioengineering.

[41]  John Thrift,et al.  The "push-to-low" approach for optimization of high-density perfusion cultures of animal cells. , 2006, Advances in biochemical engineering/biotechnology.

[42]  T. Schäfer,et al.  Modelling hybridoma cell growth and metabolism--a comparison of selected models and data. , 1996, Journal of biotechnology.